Real‐world evidence concerning clinical and economic outcomes of switching to insulin glargine 300 units/mL vs other basal insulins in patients with type 2 diabetes using basal insulin

This retrospective cohort study compared real‐world clinical and healthcare‐resource utilization (HCRU) data in patients with type 2 diabetes using basal insulin (BI) who switched to insulin glargine 300 units/mL (Gla‐300) or another BI. Data from the Predictive Health Intelligence Environment datab...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Fang Liz, Ye, Fen, Berhanu, Paulos, Gupta, Vineet E., Gupta, Rishab A., Sung, Jennifer, Westerbacka, Jukka, Bailey, Timothy S., Blonde, Lawrence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2018
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947830/
https://www.ncbi.nlm.nih.gov/pubmed/29272064
http://dx.doi.org/10.1111/dom.13199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947830/
https://www.ncbi.nlm.nih.gov/pubmed/29272064
http://dx.doi.org/10.1111/dom.13199

Ejemplares similares